CN1252081C - 制备16β-甲基甾族化合物的中间体 - Google Patents
制备16β-甲基甾族化合物的中间体 Download PDFInfo
- Publication number
- CN1252081C CN1252081C CNB981237525A CN98123752A CN1252081C CN 1252081 C CN1252081 C CN 1252081C CN B981237525 A CNB981237525 A CN B981237525A CN 98123752 A CN98123752 A CN 98123752A CN 1252081 C CN1252081 C CN 1252081C
- Authority
- CN
- China
- Prior art keywords
- acid
- formula
- ketone
- product
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
- C07J13/005—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 16 (17)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J21/005—Ketals
- C07J21/006—Ketals at position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0094—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing nitrile radicals, including thiocyanide radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
- C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
- C07J7/004—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa
- C07J7/005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa substituted in position 16
- C07J7/0055—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
- C07J71/001—Oxiranes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Toxicology (AREA)
- Steroid Compounds (AREA)
Abstract
Description
Claims (1)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9406743A FR2720747B1 (fr) | 1994-06-02 | 1994-06-02 | Nouveau procédé de préparation d'un stéroïde 16béta-méthyl et nouveaux intermédiaires. |
FR9406743 | 1994-06-02 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN95106623A Division CN1057303C (zh) | 1994-06-02 | 1995-06-01 | 制备16β-甲基甾族化合物的方法及中间体 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB200610054918XA Division CN100379753C (zh) | 1994-06-02 | 1995-06-01 | 制备16β-甲基甾族化合物的中间体 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1220996A CN1220996A (zh) | 1999-06-30 |
CN1252081C true CN1252081C (zh) | 2006-04-19 |
Family
ID=9463797
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB200610054918XA Expired - Fee Related CN100379753C (zh) | 1994-06-02 | 1995-06-01 | 制备16β-甲基甾族化合物的中间体 |
CN95106623A Expired - Fee Related CN1057303C (zh) | 1994-06-02 | 1995-06-01 | 制备16β-甲基甾族化合物的方法及中间体 |
CNB981237525A Expired - Fee Related CN1252081C (zh) | 1994-06-02 | 1998-11-04 | 制备16β-甲基甾族化合物的中间体 |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB200610054918XA Expired - Fee Related CN100379753C (zh) | 1994-06-02 | 1995-06-01 | 制备16β-甲基甾族化合物的中间体 |
CN95106623A Expired - Fee Related CN1057303C (zh) | 1994-06-02 | 1995-06-01 | 制备16β-甲基甾族化合物的方法及中间体 |
Country Status (20)
Country | Link |
---|---|
US (3) | US5596108A (zh) |
EP (1) | EP0685487B1 (zh) |
JP (1) | JP3950489B2 (zh) |
KR (1) | KR100369766B1 (zh) |
CN (3) | CN100379753C (zh) |
AT (1) | ATE157669T1 (zh) |
AU (1) | AU689564B2 (zh) |
CA (1) | CA2150738C (zh) |
DE (1) | DE69500643T2 (zh) |
DK (1) | DK0685487T3 (zh) |
ES (1) | ES2106623T3 (zh) |
FI (1) | FI114397B (zh) |
FR (1) | FR2720747B1 (zh) |
GR (1) | GR3024626T3 (zh) |
HK (1) | HK1098760A1 (zh) |
HU (1) | HU219490B (zh) |
RU (1) | RU2151774C1 (zh) |
TW (1) | TW427997B (zh) |
UA (1) | UA48107C2 (zh) |
ZA (1) | ZA954453B (zh) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10014847A1 (de) | 2000-03-24 | 2001-10-04 | Gsf Forschungszentrum Umwelt | Verfahren und Vorrichtung zum Nachweis von Verbindungen in einem Gasstrom |
CN100408025C (zh) * | 2006-11-24 | 2008-08-06 | 上海医药(集团)有限公司 | 倍他米松β-11物的自乳化组合物及其制备方法和应用 |
EP2464653B1 (en) * | 2009-08-13 | 2014-10-22 | Marinus Pharmaceuticals, Inc. | Method for making 3 -hydroxy, 3 - methyl-5 -pregnan-20-one (ganaxolone) |
CN101851264B (zh) * | 2010-03-12 | 2011-08-10 | 广西万德药业股份有限公司 | 一种具有16-β-甲基甾体类药物中间体的制备方法 |
CN103819495B (zh) * | 2014-02-28 | 2016-08-17 | 上海新华联制药有限公司 | 倍他米松中间体的制备方法 |
CN107286216A (zh) * | 2016-03-31 | 2017-10-24 | 天津金耀集团有限公司 | 具有多个烯烃甾体化合物的制备方法 |
CN105693802B (zh) * | 2016-04-12 | 2017-08-25 | 湖南新合新生物医药有限公司 | 16β‑甲基甾族化合物的制备方法 |
CN106866777B (zh) * | 2017-04-12 | 2019-05-24 | 杭州弘任医药科技有限公司 | 苯甲孕酮的制备方法 |
IT201800009683A1 (it) * | 2018-10-22 | 2020-04-22 | Ind Chimica Srl | Processo per la preparazione di 3α-idrossi-5α-pregnan-20-one (brexanolone) |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2703799A (en) * | 1954-05-12 | 1955-03-08 | Searle & Co | 9alpha-halo-11-oxo-16alpha, 17alpha-epoxyprogesterones |
US2705711A (en) * | 1954-09-24 | 1955-04-05 | Searle & Co | 9beta, 11beta; 16alpha, 17alpha-bisepoxyprogesterone |
DE1041043B (de) * | 1955-07-13 | 1958-10-16 | Nat Res Dev | Verfahren zur Herstellung von 17ª‡-Hydroxy-16-halogenallopregnanen |
GB805497A (en) * | 1955-07-13 | 1958-12-10 | Glaxo Lab Ltd | Steroid intermediates for the preparation of adreno-cortical hormones |
US2951857A (en) * | 1956-03-13 | 1960-09-06 | Searle & Co | 11-oxygenated 16-halo-17-hydroxy-progesterones |
US3219674A (en) * | 1959-03-11 | 1965-11-23 | Syntex Corp | 15-dehydro-16 methyl steroids and process for the production thereof |
US3761498A (en) * | 1971-06-05 | 1973-09-25 | Plurichemie Anstalt | New process of preparation of steroids |
KR960010793B1 (ko) * | 1986-10-10 | 1996-08-08 | 루쎌 위클라프 소시에떼 아노님 | 9-알파-히드록시 스테로이드 및 그의 제조방법 |
HU198736B (en) * | 1986-12-29 | 1989-11-28 | Gyogyszerkutato Intezet | Process for producing 16-dehydro-20-oxopregnane derivatives |
-
1994
- 1994-06-02 FR FR9406743A patent/FR2720747B1/fr not_active Expired - Fee Related
-
1995
- 1995-05-15 TW TW084104785A patent/TW427997B/zh not_active IP Right Cessation
- 1995-05-18 US US08/444,229 patent/US5596108A/en not_active Expired - Lifetime
- 1995-05-31 ZA ZA954453A patent/ZA954453B/xx unknown
- 1995-05-31 JP JP15546595A patent/JP3950489B2/ja not_active Expired - Fee Related
- 1995-06-01 UA UA95062622A patent/UA48107C2/uk unknown
- 1995-06-01 RU RU95108877/04A patent/RU2151774C1/ru not_active IP Right Cessation
- 1995-06-01 CN CNB200610054918XA patent/CN100379753C/zh not_active Expired - Fee Related
- 1995-06-01 CA CA002150738A patent/CA2150738C/fr not_active Expired - Fee Related
- 1995-06-01 KR KR1019950014481A patent/KR100369766B1/ko not_active IP Right Cessation
- 1995-06-01 ES ES95401273T patent/ES2106623T3/es not_active Expired - Lifetime
- 1995-06-01 AU AU20442/95A patent/AU689564B2/en not_active Ceased
- 1995-06-01 HU HU9501595A patent/HU219490B/hu not_active IP Right Cessation
- 1995-06-01 DK DK95401273.8T patent/DK0685487T3/da active
- 1995-06-01 EP EP95401273A patent/EP0685487B1/fr not_active Expired - Lifetime
- 1995-06-01 CN CN95106623A patent/CN1057303C/zh not_active Expired - Fee Related
- 1995-06-01 DE DE69500643T patent/DE69500643T2/de not_active Expired - Lifetime
- 1995-06-01 AT AT95401273T patent/ATE157669T1/de active
- 1995-06-02 FI FI952718A patent/FI114397B/fi not_active IP Right Cessation
-
1996
- 1996-09-13 US US08/710,198 patent/US5795982A/en not_active Expired - Lifetime
-
1997
- 1997-09-04 GR GR970402264T patent/GR3024626T3/el unknown
-
1998
- 1998-04-22 US US09/064,576 patent/US6117994A/en not_active Expired - Lifetime
- 1998-11-04 CN CNB981237525A patent/CN1252081C/zh not_active Expired - Fee Related
-
2007
- 2007-02-23 HK HK07102100A patent/HK1098760A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1237069C (zh) | 5-0-德糖胺基-6-0-甲基-红诺霉素a衍生物在制备生物活性产品方法的应用 | |
CN1098101A (zh) | 虾青素的制备、制备它的新中间体以及其制备 | |
CN1252081C (zh) | 制备16β-甲基甾族化合物的中间体 | |
CN1030081C (zh) | 新的11-芳基甾族化合物的制备方法 | |
CN101065396A (zh) | 屈螺酮的制备方法 | |
CN1147520A (zh) | 11-(取代的苯基)-雌-4,9-二烯衍生物 | |
CN1479746A (zh) | 制备7-取代抗雌激素的方法及中间体 | |
CN1070499C (zh) | 6α,9α-二氟化甾族化合物的制备方法和中间体 | |
CN1039646C (zh) | 11-酮甾衍生物的制备方法 | |
CN1052489C (zh) | 制备16α-甲基甾族化合物的方法 | |
CN1095847C (zh) | 新的17,20-环氧孕甾烷衍生物 | |
CN1035947C (zh) | 制备氢化可的松的新方法和新中间体 | |
CN1035948C (zh) | 孕甾-1,4-二烯-3,20-二酮衍生物的制备方法 | |
CN1257143C (zh) | 无需催化剂的加成反应 | |
US6696580B2 (en) | Process for the production of 6,7-diols of steroidal compounds | |
CN1103643A (zh) | 16α-甲基化甾族化合物的新制备方法 | |
JP2010013653A (ja) | アルコール性水酸基を有する有機ケイ素樹脂及びその製造方法 | |
CN1100406A (zh) | 环戊烯醇衍生物的制备方法 | |
CN87107342A (zh) | 23位上酮基的甾族化合物,其制备方法及用其制备20酮孕甾烷 | |
CN1045004C (zh) | 制备胡萝卜素类化合物的方法 | |
CN1036719C (zh) | 制备孕烷的20-氧代-17α,21-二羟基衍生物的方法 | |
CN1152045C (zh) | 制备4,4-二甲基-3β-羟基孕-8,14-二烯-21-羧酸酯的方法及中间体 | |
CN1172909C (zh) | 四烯衍生物及其生产方法 | |
CN1474829A (zh) | 制备4-(17α-取代的-3-氧化雌-4,9-二烯-11β-基)苯甲醛-(1E或1Z)-肟的方法 | |
Terunuma et al. | Preparation of New 7-Silanorbornene Derivatives and Their Reaction with Some Nucleophiles. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C06 | Publication | ||
PB01 | Publication | ||
C12 | Rejection of a patent application after its publication | ||
RJ01 | Rejection of invention patent application after publication | ||
ASS | Succession or assignment of patent right |
Owner name: HOECHST MARION ROUSSEL INC. Free format text: FORMER OWNER: ROUSSEL-UCLAF Effective date: 20050422 Owner name: VENTIS PHARMA S.A. Free format text: FORMER OWNER: HOECHST MARION ROUSSEL INC. Effective date: 20050422 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20050422 Address after: French Anthony Applicant after: AVENTIS PHARMA S.A. Address before: French AUX Applicant before: Hoechst Marion Roussel Effective date of registration: 20050422 Address after: French AUX Applicant after: HOECHST MARION ROUSSEL Address before: French Roman Applicant before: ROUSSEL UCLAF |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20060419 Termination date: 20140601 |